IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
Impact in
- Cancer Research 282
Classified as
- Journal
- The Journal of Pathology
In The Last Decade
doi.org/10.1002/path.2913 →Countries where authors are citing IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
This map shows the geographic impact of IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours more than expected).
Fields of papers citing IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
This network shows the impact of IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.
About IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
This paper, published in 2011, received 723 indexed citations . Written by Maria Fernanda Amary, Krisztián Bácsi, Francesca Maggiani, Stephen Damato, Dina Halai, Fitim Berisha, Robin Pollock, Paul O’Donnell, Anita Grigoriadis and Tim C. Diss covering the research area of Cancer Research, Rheumatology and Pulmonary and Respiratory Medicine. It is primarily cited by scholars working on Cancer Research (282 citations), Pulmonary and Respiratory Medicine (259 citations), Rheumatology (248 citations), Molecular Biology (247 citations) and Genetics (165 citations). Published in The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1002/path.2913.